Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company under the name of Natco Fine Pharmaceuticals Private Limited. It became a deemed public company ...

Mylan’s long-awaited rival for Teva’s blockbuster multiple sclerosis drug Copaxone has been approved in the US, putting a large chunk of the Israeli firm’s revenues at risk. The timing could ...

AUSTEDO ® - shows continued strong growth, with worldwide revenues of $411 million in Q1 2025, an increase of 39% in local ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Both Scheffler, who believes his game is trending in the right direction, and Spieth, who needed the injection of confidence that he received in the Byron Nelson, will be a focus in Charlotte in ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

In its upcoming report, Teva Pharmaceutical Industries Ltd. (TEVA) is predicted by Wall Street analysts to post quarterly earnings of $0.47 per share, reflecting a decline of 2.1% compared to the ...

OKAY. DOCTOR RAJ Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER ...

“But I think people just see these drugs as a magic fix. So they take the injection, and they kind of just go along with their lives, and they don’t make the lifestyle changes. They don’t ...

Analysts expect 'Revenue- COPAXONE- Total' to come in at $84.97 million. The estimate points to a change of -14.2% from the year-ago quarter. Analysts predict that the 'Revenue- API sales to third ...

Health officials are poised to announce trials to significantly widen access to the revolutionary injections. They will allow NHS patients to get the jabs directly from pharmacies after a short ...

18 months after it opened an investigation into Teva to see if it illegally blocked generic versions of its big-selling multiple sclerosis drug Copaxone, the European Commission has said it thinks ...